MarketsStocksGUFICBIO
GU

Gufic Biosciences Ltd

NSE: GUFICBIOBSE: 509079Healthcare
Download Research Report7-page PDF
377.00
+1.91%
NSE · auto-updates while market open
Prev Close
₹368.10
Day High
₹398.80
Day Low
₹367.80
Mkt Cap
₹3,852 Cr
P / E
60.0
P / B
5.8
ROE
10.1%
52W High
₹407.85
52W Low
₹268.00
Key Metrics
Market Cap
₹3,852 Cr
P / E
59.98
P / B
5.80
EV / EBITDA
26.56
ROCE
12.6%
ROE
10.1%
Debt / Equity
0.58
Book Value
₹66.31
EPS
₹6.40
Div Yield
0.0%
Face Value
₹1
Promoter Holding
72.5%
Revenue · ₹ Cr
358
FY20
488
FY21
779
FY22
691
FY23
807
FY24
820
FY25
944
FY26
Net Profit · ₹ Cr
23
FY20
44
FY21
96
FY22
80
FY23
86
FY24
70
FY25
64
FY26
EPS · ₹ per share
₹2.9
FY20
₹4.6
FY21
₹9.9
FY22
₹8.2
FY23
₹8.7
FY24
₹7.0
FY25
₹6.4
FY26
P / E Ratio · price ÷ TTM EPS
133353731150-1Jun 21Feb 23Oct 24Jun 26
P/E 58.9×Median 41.1×TTM EPS
Q1 2026 snapshot
Sales
₹251 Cr
Operating profit
-
OPM
-
Net profit
₹22 Cr
EPS
₹2.18
Scorecard · 7 axes
Quality
Avg
46/100
Valuation
Weak
60.0×
Growth
Bad
-2.3%
Profitability
Avg
11.4%
Performance
Weak
+0.1%
Entry Point
Weak
92%
Red Flags
Strong
0 flags
Shareholding Pattern
72.5%Promoter
Promoter72.5%
FII0.4%
DII3.8%
Public23.3%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue207.794205.41224.65239.17232.2250.65
Net Profit19.3057.7213.0716.82312.42421.896
NPM %9.3%3.8%5.8%7.0%5.4%8.7%
AlertPre-trade